| Jul 28, 2021 |
2021 FCA 154 |
Seedlings v. Pfizer
We successfully represented Pfizer on this appeal related to a mechanical device patent and Pfizer’s epinephrine auto injector product EpiPen...
|
Patents
|
|
| Mar 4, 2021 |
2021 FCA 45 |
Apotex v. Janssen
We successfully represented Janssen on this appeal. The Federal Court of Appeal upheld the trial judge’s decision that the patent was valid a...
|
Patents
|
|
| Jan 14, 2021 |
2021 FC 7 |
Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories
We represented Janssen and BTG in these patent infringement actions relating to Janssen’s prostate cancer product ZYTIGA®(abiraterone ace...
|
Patents
|
|
| Jan 2, 2020 |
2020 FC 1 |
Seedlings Life Sciences v Pfizer
We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...
|
Patents
|
|
| Oct 29, 2019 |
2019 FC 1355 |
Janssen Inc. et al v Apotex Inc.
We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” applica...
|
Patents
|
|
| Feb 8, 2018 |
2018 FCA 33 |
Teva Canada Limited v. Janssen Inc.
We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...
|
Patents
|
|
| Feb 6, 2018 |
2018 FCA 32 |
Apotex Inc. v. Bayer Inc.
We successfully represented Bayer Inc. on this appeal, which upheld the patentee’s right to elect its damages.
|
Patents
|
|
| Dec 9, 2016 |
2016 FC 1361 |
Janssen Inc. et al. v. Actavis Pharma Company et al.
We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA. The generic company Actavis Pharma had challen...
|
Patents
|
|
| Sep 9, 2016 |
2016 FC 1013 |
Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company
We successfully represented Bayer in this patent infringement action. Following a six week trial, the Federal Court agreed that Bayer’s paten...
|
Patents
|
|
| May 31, 2016 |
2016 FC 593 |
Janssen Inc. v. Teva Canada Limited
We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....
|
Patents
|
|